Akonni receives NSF's Phase 2 SBIR Grant to develop Lab-on-a-Film microarray

NewsGuard 100/100 Score

Akonni Biosystems, a life science tools / molecular diagnostics company that develops, manufactures, and plans to market molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $498,780 Phase 2 SBIR Grant from the National Science Foundation (NSF). This second round of funding from NSF will enable Akonni to further develop its Lab-on-a-Film microarray consumable that can be manufactured on ultra-low-cost film using a highly automated, reel-to-reel production process.    

"Reel-to-reel assembly is a method of high volume manufacturing used predominantly for the assembly of lateral flow strips and flexible film electronics," said Dr. Christopher Cooney, Principal Investigator on the grant and Director of Engineering at Akonni Biosystems. "The benefit of this manufacturing approach is that Lab-on-a-Film microarray production and assembly can be automated at very high speeds, resulting in ten- to one hundred-fold savings in consumable costs."

Lab-on-a-Film manufacturing has the potential to produce mid-multiplexed microarray consumables for just a few dollars. Combining low-cost production with the multiplexing power of Akonni's gel-drop microarrays, to simultaneously interrogate tens to hundreds of disease markers in a single clinical sample, offers the potential to change the economics of patient wellness monitoring and disease diagnosis. This is especially true in global health settings, where end user adoption of a technology depends critically on cost.

Among projected applications for the Lab-on-a-Film consumable is its integration into the Akonni hands-free, end-to-end genetic testing system. This system is currently being designed for use in moderate-complexity lab settings. It primarily uses Akonni-developed intellectual property, which includes technology that covers cell lysis, rapid nucleic acid extraction (TruTip®), thermocycling, amplification (On-Chip PCR™), and microarray imaging and analysis. Eventual use of Lab-on-a-Film consumables is anticipated in systems designed for CLIA-waved settings.        

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
RNA editing using CRISPRs shows promise for genetic disease treatment